From Commercialization to Global Leadership: Innogen (2591.HK) Unlocks the Strategic Value of Its Ultra-Long-Acting GLP-1 Receptor Agonist

B HONG KONG, April 1, 2026 /PRNewswire/ — The release of Innogen’s inaugural annual report following its Hong Kong listing serves not merely as a financial…

posteditor
posteditor
Articles: 27298

Other News